2022 Consensus Statement on the Management of Familial Hypercholesterolemia in Korea-Reference-Cited by-同舟云学术

2022 Consensus Statement on the Management of Familial Hypercholesterolemia in Korea

Published:2022 Issue:3 Volume:11 Page:213
ISSN:2287-2892
Container-title:Journal of Lipid and Atherosclerosis
language:en
Short-container-title:J Lipid Atheroscler

Author:

Lee Chan Joo¹^ORCID,Yoon Minjae²^ORCID,Kang Hyun-Jae³^ORCID,Kim Byung Jin⁴^ORCID,Choi Sung Hee⁵^ORCID,Jeong In-Kyung⁶^ORCID,Lee Sang-Hak¹^ORCID,

Affiliation:

1. Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

2. Cardiovascular Center, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

3. Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

4. Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

5. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

6. Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea.

Funder

Korean Society of Lipid and Atherosclerosis

Publisher

Korean Society of Lipidology and Atherosclerosis

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://e-jla.org/pdf/10.12997/jla.2022.11.3.213

Reference52 articles.

1. Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review

2. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217

3. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic Review;Yonsei Medical Journal;2024

2. Advancing Familial Hypercholesterolemia Detection and Management in South Korea;Korean Circulation Journal;2024

3. Development and Validation of Multiple Equations for Low-Density Lipoprotein and Apolipoprotein B in Korean Patients Visiting Local Clinics and Hospitals;Nutrients;2023-06-17